T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

• Published in: Journal of neuroimmunology 2002-09, Vol.130 (1), p.233-242
• Main Authors: Muraro, P.A, Kalbus, M, Afshar, G, McFarland, H.F, Martin, R
• Format: Article
• Language: English
• Subjects: 2',3'-Cyclic-Nucleotide Phosphodiesterases - immunology; 2′,3′-Cyclic nucleotide 3′-phosphodiesterase; Adult; Antigens, Surface - immunology; CD4-Positive T-Lymphocytes - enzymology; CD4-Positive T-Lymphocytes - immunology; Cell Culture Techniques - methods; Cell Division - immunology; Cells, Cultured; Epitopes; Female; HLA-DR Antigens - immunology; Humans; Male; Middle Aged; Multiple sclerosis; Multiple Sclerosis - enzymology; Multiple Sclerosis - immunology; Myelin proteins; Myelin Proteins - immunology; Phenotype; T-Lymphocytes - enzymology; T-Lymphocytes - immunology
• ISSN: 0165-5728; 1872-8421
• DOI: 10.1016/S0165-5728(02)00229-1

T cell responses targeting myelin antigens are possibly involved in the pathogenesis of demyelinating diseases, such as multiple sclerosis (MS). Little is known about human T cell responses to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase), the third most abundant myelin protein. We examined the primary peripheral T cell response to CNPase and characterized CNPase-specific CD4+ long-term T cell lines (TCL) from MS patients and healthy donors. The strongest primary responses were found in two MS patients with very active disease and were directed against CNP(343–373). We identified immunodominant epitope clusters in the regions CNP(343–373) and (356–388) that were recognized in the context of MS-associated HLA-DR2 and DR4 molecules. These data provide the immunological basis for further investigation of CNPase as a potential target self-antigen in MS.